Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Cancer Research
|
December 21, 2017
LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells
Chungang Liu, Limei Liu, Xuejiao Chen, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
December 5, 2024
Adjusting Interface Action and Spacing for Control of Particle Potential
Mian Qin, Jiangsong Ren, Jiamin Cheng, et al.
Hepatology International
|
December 29, 2022
Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors
Jin Lei, Tao Yan, Linzhi Zhang, et al.
Science Bulletin
|
January 20, 2026
Corrigendum to "Engineered platelets-based nano-aircraft system for precise tumor chemo-immunotherapy with graded drug delivery and self-recognized tumor targeting" [Sci. Bull. 70(9) (2025) 1462-1477]
Meijuan Geng, Huiping Du, Xuan Wei, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
August 13, 2021
Percutaneous Argon-Helium Cryoablation for Small Hepatocellular Carcinoma Located Adjacent to a Major Organ or Viscus: A Retrospective Study of 92 Patients at a Single Center
Wei Zhang, Xudong Gao, Jie Sun, et al.
Journal of Hepatocellular Carcinoma
|
September 22, 2025
A Multicenter Retrospective Study: Impact of First-Line Treatment Strategies on second-Line Efficacy and Safety of Regorafenib with or Without PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
Weihong Ma, Yinyin Li, Yinying Lu, et al.
Science Bulletin
|
February 20, 2025
Engineered platelets-based nano-aircraft system for precise tumor chemo-immunotherapy with graded drug delivery and self-recognized tumor targeting
Meijuan Geng, Huiping Du, Xuan Wei, et al.
Research (Washington, D.C.)
|
September 8, 2025
Delivery-Graded Programmable Micelles Achieve Enhanced Tumor Starvation through Combined Glutamine Deprivation and Angiogenesis Inhibition
Xuan Wei, Jiamin Cheng, Meijuan Geng, et al.
Hepatology (Baltimore, Md.)
|
February 25, 2016
Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma
Chungang Liu, Limei Liu, Xuejiao Chen, et al.
Drug Design, Development and Therapy
|
January 4, 2023
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
Bowen Chen, Linzhi Zhang, Jiamin Cheng, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Cancer Research
|
December 21, 2017
LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells
Chungang Liu, Limei Liu, Xuejiao Chen, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
December 5, 2024
Adjusting Interface Action and Spacing for Control of Particle Potential
Mian Qin, Jiangsong Ren, Jiamin Cheng, et al.
Hepatology International
|
December 29, 2022
Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors
Jin Lei, Tao Yan, Linzhi Zhang, et al.
Science Bulletin
|
January 20, 2026
Corrigendum to "Engineered platelets-based nano-aircraft system for precise tumor chemo-immunotherapy with graded drug delivery and self-recognized tumor targeting" [Sci. Bull. 70(9) (2025) 1462-1477]
Meijuan Geng, Huiping Du, Xuan Wei, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
August 13, 2021
Percutaneous Argon-Helium Cryoablation for Small Hepatocellular Carcinoma Located Adjacent to a Major Organ or Viscus: A Retrospective Study of 92 Patients at a Single Center
Wei Zhang, Xudong Gao, Jie Sun, et al.
Journal of Hepatocellular Carcinoma
|
September 22, 2025
A Multicenter Retrospective Study: Impact of First-Line Treatment Strategies on second-Line Efficacy and Safety of Regorafenib with or Without PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
Weihong Ma, Yinyin Li, Yinying Lu, et al.
Science Bulletin
|
February 20, 2025
Engineered platelets-based nano-aircraft system for precise tumor chemo-immunotherapy with graded drug delivery and self-recognized tumor targeting
Meijuan Geng, Huiping Du, Xuan Wei, et al.
Research (Washington, D.C.)
|
September 8, 2025
Delivery-Graded Programmable Micelles Achieve Enhanced Tumor Starvation through Combined Glutamine Deprivation and Angiogenesis Inhibition
Xuan Wei, Jiamin Cheng, Meijuan Geng, et al.
Hepatology (Baltimore, Md.)
|
February 25, 2016
Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma
Chungang Liu, Limei Liu, Xuejiao Chen, et al.
Drug Design, Development and Therapy
|
January 4, 2023
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
Bowen Chen, Linzhi Zhang, Jiamin Cheng, et al.
Page
of 5